rs148536791

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_015214.3(DDHD2):​c.2047T>A​(p.Cys683Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00268 in 1,613,460 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 8 hom. )

Consequence

DDHD2
NM_015214.3 missense

Scores

4
10
4

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 7.94

Publications

6 publications found
Variant links:
Genes affected
DDHD2 (HGNC:29106): (DDHD domain containing 2) This gene encodes a phospholipase enzyme containing sterile-alpha-motif (SAM), WWE, and DDHD domains. This protein participates in membrane trafficking between the endoplastic reticulum and the Golgi body. Mutations in this gene can cause autosomal recessive spastic paraplegia 54. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
DDHD2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 54
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020032167).
BP6
Variant 8-38253711-T-A is Benign according to our data. Variant chr8-38253711-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 473072.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00242 (369/152364) while in subpopulation NFE AF = 0.00284 (193/68034). AF 95% confidence interval is 0.00251. There are 1 homozygotes in GnomAd4. There are 189 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DDHD2NM_015214.3 linkc.2047T>A p.Cys683Ser missense_variant Exon 16 of 18 ENST00000397166.7 NP_056029.2 O94830-1B3KPM6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DDHD2ENST00000397166.7 linkc.2047T>A p.Cys683Ser missense_variant Exon 16 of 18 2 NM_015214.3 ENSP00000380352.2 O94830-1

Frequencies

GnomAD3 genomes
AF:
0.00242
AC:
369
AN:
152246
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000772
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0116
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00284
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00261
AC:
653
AN:
250586
AF XY:
0.00266
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000407
Gnomad ASJ exome
AF:
0.00279
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0106
Gnomad NFE exome
AF:
0.00321
Gnomad OTH exome
AF:
0.00246
GnomAD4 exome
AF:
0.00271
AC:
3954
AN:
1461096
Hom.:
8
Cov.:
31
AF XY:
0.00267
AC XY:
1939
AN XY:
726874
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33438
American (AMR)
AF:
0.000449
AC:
20
AN:
44576
Ashkenazi Jewish (ASJ)
AF:
0.00264
AC:
69
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86106
European-Finnish (FIN)
AF:
0.0119
AC:
638
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00278
AC:
3085
AN:
1111638
Other (OTH)
AF:
0.00219
AC:
132
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
178
355
533
710
888
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00242
AC:
369
AN:
152364
Hom.:
1
Cov.:
32
AF XY:
0.00254
AC XY:
189
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000769
AC:
32
AN:
41598
American (AMR)
AF:
0.000523
AC:
8
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0116
AC:
123
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00284
AC:
193
AN:
68034
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00254
Hom.:
1
Bravo
AF:
0.00143
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00221
AC:
19
ExAC
AF:
0.00297
AC:
360
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00191
EpiControl
AF:
0.00207

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DDHD2: BS1, BS2 -

not specified Benign:1
Nov 21, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hereditary spastic paraplegia 54 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
May 01, 2018
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.91
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.46
T;T;.;D;D
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
.;D;D;D;D
MetaRNN
Benign
0.020
T;T;T;T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Uncertain
2.0
M;M;.;.;.
PhyloP100
7.9
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-8.3
D;D;D;D;D
REVEL
Uncertain
0.39
Sift
Uncertain
0.0020
D;D;D;D;T
Sift4G
Uncertain
0.011
D;D;D;D;D
Polyphen
0.87
P;P;.;.;.
Vest4
0.81
MutPred
0.66
Gain of disorder (P = 0.0086);Gain of disorder (P = 0.0086);.;.;.;
MVP
0.61
MPC
0.71
ClinPred
0.062
T
GERP RS
5.1
PromoterAI
0.017
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.82
gMVP
0.63
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148536791; hg19: chr8-38111229; COSMIC: COSV106114201; COSMIC: COSV106114201; API